Advanced search×

VEGF gene polymorphisms may be associated with an increased risk of fluorouracil-induced diarrhea.

V V Formica, L L Martano, R R Palmirotta, P P Ferroni, G G Del Monte, F F Guadagni, and M M Roselli

Ann Oncol 22(8):1928-9 (2011) PMID 21555362

DOI: 10.1093/annonc/mdr273
Version: za2963e q8za3 q8zb5 q8zcd q8zd6 q8zed q8zfd q8zg8
Buy PDF

Similar articles you may find interesting…

  1. Factors associated with reduced efficacy of sitagliptin therapy: analysis of 93 patients with type 2 diabetes treated for 1.5 years or longe...
    Akira Kanamori and Ikuro Matsuba

    J Clin Med Res 5(3):217-21 (2013) PMID 23671547

    Several studies have shown the effectiveness of sitagliptin, a dipeptidyl peptidase-4 inhibitor, for type 2 diabetes, with a hypoglycemic effect being demonstrated both when it is administered alone or in combination with other oral antidiabetic agents. However, there are few reports...
    PDF not found
  2. Genetic Mediators of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia.
    Kevin R Krull, Deepa Bhojwani, and Ching-Hon Pui

    J Clin Oncol (2013) PMID 23650422

    PURPOSESurvivors of childhood acute lymphoblastic leukemia (ALL) are at increased risk for neurocognitive problems, with significant interindividual variability in outcome. This study examined genetic polymorphisms associated with variability in neurocognitive outcome. PATIENTS AND M...
    Buy PDF
  3. The role of the MTHFR 677C>T polymorphism in methotrexate-induced liver toxicity: a meta-analysis in patients with cancer.
    M M Hagleitner, M J H Coenen, and D M W M Te Loo

    Pharmacogenomics J (2013) PMID 23648444

    Methotrexate (MTX), one of the important pillars in the treatment of different forms of cancer, is associated with the development of hepatotoxicity. The 677C>T variant (rs1801133) in the methylenetetrahydrofolate reductase (MTHFR) gene might affect the development of hepatotoxicity....
    Buy PDF